These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30741929)

  • 1. Validation of the Mayo alliance prognostic system for mastocytosis.
    Mannelli F; Gesullo F; Rotunno G; Pacilli A; Pieri L; Guglielmelli P; Vannucchi AM
    Blood Cancer J; 2019 Feb; 9(2):18. PubMed ID: 30741929
    [No Abstract]   [Full Text] [Related]  

  • 2. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.
    Valent P; Akin C; Metcalfe DD
    Blood; 2017 Mar; 129(11):1420-1427. PubMed ID: 28031180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, progression patterns and prognostication in mastocytosis.
    Sperr WR; Valent P
    Expert Rev Hematol; 2012 Jun; 5(3):261-74. PubMed ID: 22780207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the pathogenesis, diagnosis, and management of mastocytosis.
    Fuller SJ
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1143-68. PubMed ID: 23116574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mastocytosis--diagnostic criteria and treatment].
    Dereń-Wagemann I; Kuliszkiewicz-Janus M; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():564-76. PubMed ID: 20009120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.
    Volertas S; Schuler CF; Akin C
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis.
    Tefferi A; Shah S; Reichard KK; Hanson CA; Pardanani A
    Am J Hematol; 2019 Jan; 94(1):E1-E2. PubMed ID: 30281840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic mastocytosis. A little-known disease].
    Carrillo Muñoz R; Blanco Blanco A; Alegre Martín J; Capdevila Morell JA; Fernández de Sevilla T; Martínez Vázquez JM
    An Med Interna; 1993 Mar; 10(3):138-42. PubMed ID: 8485285
    [No Abstract]   [Full Text] [Related]  

  • 9. Mast cell activation syndromes and anaphylaxis: Multiple diseases part of the same spectrum.
    González-de-Olano D; Matito A; Alvarez-Twose I
    Ann Allergy Asthma Immunol; 2020 Feb; 124(2):143-145.e1. PubMed ID: 31785366
    [No Abstract]   [Full Text] [Related]  

  • 10. Perioperative management of patients with mastocytosis.
    Dewachter P; Castells MC; Hepner DL; Mouton-Faivre C
    Anesthesiology; 2014 Mar; 120(3):753-9. PubMed ID: 24135579
    [No Abstract]   [Full Text] [Related]  

  • 11. Mastocytosis: recent advances in defining the disease.
    Hartmann K; Henz BM
    Br J Dermatol; 2001 Apr; 144(4):682-95. PubMed ID: 11298525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
    Akin C
    J Mol Diagn; 2006 Sep; 8(4):412-9. PubMed ID: 16931579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastocytosis: diverse presentations and outcomes.
    Pauls JD; Brems J; Pockros PJ; Saven A; Wagner RL; Weber R; Metcalfe D; Christiansen SC
    Arch Intern Med; 1999 Feb; 159(4):401-5. PubMed ID: 10030315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell disease.
    Schneider I; Schwartz RA
    Cutis; 1997 Feb; 59(2):63-6. PubMed ID: 9040973
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.
    Broesby-Olsen S; Dybedal I; Gülen T; Kristensen TK; Møller MB; Ackermann L; Sääf M; Karlsson MA; Agertoft L; Brixen K; Hermann P; Stylianou E; Mortz CG; Torfing T; Havelund T; Sander B; Bergström A; Bendix M; Garvey LH; Bjerrum OW; Valent P; Bindslev-Jensen C; Nilsson G; Vestergaard H; Hägglund H
    Acta Derm Venereol; 2016 Jun; 96(5):602-12. PubMed ID: 26694951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical thinking and decision-making in practice. A patient with episodes of flushing].
    Stehouwer CD; Gans RO
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):792-6. PubMed ID: 10347642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric mastocytosis.
    Kettelhut BV; Metcalfe DD
    J Invest Dermatol; 1991 Mar; 96(3):15S-18S. PubMed ID: 1705949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastocytosis.
    Kumar S; Moody P
    Pediatr Rev; 2001 Jan; 22(1):33-4. PubMed ID: 11139646
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mastocytosis].
    Borbujo Martínez J
    Rev Clin Esp; 1998 Jun; 198(6):343-4. PubMed ID: 9691738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.